Home / Health / Young Woman Battles Triple Negative Breast Cancer
Young Woman Battles Triple Negative Breast Cancer
3 Oct
Summary
- Chance Osborne discovered a lump at age 24, diagnosed with aggressive cancer.
- She has the BRCA1 gene, increasing her risk for breast and ovarian cancers.
- Osborne advocates for genetic testing as an empowering life-saving tool.
Chance Osborne, now 30, discovered a lump in her breast at age 24, two weeks after a clear MRI. This lump rapidly grew into triple negative breast cancer, a highly aggressive form. Osborne's family history includes her mother's ovarian cancer death in 2011, and she herself was found to have the BRCA1 gene, significantly increasing her risk.
Her treatment involved chemotherapy from April to August 2021, followed by surgery, radiation, a double mastectomy with unsuccessful reconstruction, and a preventative total hysterectomy. She also underwent 372 days of medication and is now a five-year survivor.
Osborne found solace and information through social media, eventually discovering Signatera, a test that helps detect cancer relapses early. She now works for its parent company, Natera, and undergoes testing every three months. She advocates strongly for genetic testing, asserting it is intended to empower individuals to make informed, life-saving decisions, regardless of family history or age.
